Bibliometric and Visual Analysis of Fibrotic Pulmonary Sarcoidosis

Author:

WEI NAMIN1,Fang Xinhua2,Zhao Xuelong3,Zeng Fengping1,Yu Chenqian1,Huyen Nguyen Thi Thanh1,Li Feiyu1,Chen Hongmei2,Zhai Huaqiang1

Affiliation:

1. Beijing University of Chinese Medicine

2. Hangzhou Traditional Chinese Medicine Hospital

3. Nanjing Traditional Chinese Medicine Hospital

Abstract

Abstract Background Fibrotic pulmonary sarcoidosis (FPS) has a high mortality rate, but its pathogenesis is not clear and effective treatments are lackings. In recent years, numerous literature reviews have been published from various perspectives on FPS. However, there is still a lack of visual analysis and summary of its research status, hotspots, and development trends. Therefore, to fill this knowledge gap, this study conducted a bibliometric and visual analysis of the published literature on FPS. Methods A total of 962 relevant publications were extracted from the Web of Science Core Collection. CiteSpace was used to conduct a bibliometric analysis and draw knowledge maps from five dimensions: publication years and document types, scientific collaboration networks (authors, countries/territories and institutions), journals, references and keywords. Results Current FPS research exhibits steady growth, capturing widespread attention. Noteworthy authors include Bargagli E, Baughman RP, Valeyre D, Raghu G, and Hunninghake GW. USA, Italy, Germany, England, and Netherlands demonstrate relatively mature research in this field. Three influential research institutions, namely Royal Brompton Hospital (England), Imperial College London (England) and University of California System (USA), stand out in this field. Important journals include American Journal of Respiratory and Critical Care Medicine, European Respiratory Journal, Chest, Thorax and Respiratory Medicine. These journals primarily focus on the evaluation, clinical and immunological characteristics, and treatment of FPS. Current hot research topics mainly include FPS-relevant diseases (interstitial lung disease, idiopathic pulmonary fibrosis and pulmonary fibrosis), complications (pulmonary hypertension, chronic obstructive pulmonary disease, and lung cancer), commonly used treatments (bronchoalveolar lavage), and biomarkers (YKL-40). Diagnosis, treatment (clinical trial drug studies), cardiac sarcoidosis, and quality of life are currently in an explosive stage and will be the focus of future research. Conclusion This research provides useful information for the study of FPS, including potential collaborators, research status of various countries and institutions, distribution and knowledge structure of journals, as well as research status and hotspots, providing a reference for future broader and deeper research.

Publisher

Research Square Platform LLC

Reference115 articles.

1. Sarcoidosis: a review for the internist;Bargagli E;Intern Emerg Med,2018

2. Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline;Crouser ED;Am J Respir Crit Care Med,2020

3. Pathology of Sarcoidosis;Rossi G;Clin Rev Allergy Immunol,2015

4. Why do people die from pulmonary sarcoidosis?;Kouranos V;Curr Opin Pulm Med,2018

5. Atypical HRCT manifestations of pulmonary sarcoidosis;Cozzi D;Radiol Med,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3